← Back to Briefing
Novo Nordisk Data Breach: Hackers Claim to Sell Stolen Drug Recipes and AI Models After Unpaid Ransom
Importance: 90/1001 Sources
Why It Matters
This incident highlights the significant risk of cyberattacks on pharmaceutical companies, potentially exposing valuable intellectual property and research data, which could impact competitive advantage and future drug development.
Key Intelligence
- ■Hackers claim to have exfiltrated sensitive data, including drug recipes and AI models, from Novo Nordisk.
- ■The cybercriminals reportedly demanded a $25 million ransom from the pharmaceutical giant.
- ■Novo Nordisk declined to pay the ransom, leading the hackers to offer the stolen data for sale.
- ■The incident raises concerns about the potential compromise of proprietary intellectual property and research.